English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Miltefosine (Impavido): the first oral treatment against leishmaniasis

MPS-Authors
/persons/resource/persons15029

Eibl,  H.
Research Group of Phospholipids, MPI for biophysical chemistry, Max Planck Society;

Locator
There are no locators available
Fulltext (public)
There are no public fulltexts available
Supplementary Material (public)
There is no public supplementary material available
Citation

Sindermann, H., Croft, S. L., Engel, K. R., Bommer, W., Eibl, H., Unger, C., et al. (2004). Miltefosine (Impavido): the first oral treatment against leishmaniasis. Medical Microbiology and Immunology, 193(4), 173-180. Retrieved from http://www.springerlink.com/content/qhh4kh9a38137u6h/fulltext.pdf.


Cite as: http://hdl.handle.net/11858/00-001M-0000-0012-EBFA-C
Abstract
There is no abstract available